CARES Foundation does not counsel individual patients either for or against participation in any specific research study. Prospective volunteers should always carefully review the study’s informed consent documentation and discuss the pros and cons of their participation with trusted advisers, including their health care providers and family members. For more information on research participation, check out https://www.hhs.gov/ohrp/education-and-outreach/about-research-participation/index.html
For more information on any of the below research proposals, please contact klin@med.cornell.edu
1. Relationship Between Adipokines and Androgens in Children and Young Adults with CAH: Prospective cross-sectional observational study to evaluate the impact of glucocorticoid dosing on metabolic risk factors in our patient population of children and young adults with congenital adrenal hyperplasia. The manuscript is currently under review for publication in Frontiers in Endocrinology.
2. Neurocrine Biosciences: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Pediatric Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment. Phase 3 study. Protocol number: NBI-74788-CAH2006. Weill Cornell Medicine is a site and has enrolled two subjects.
3. Anastrozole Therapy to Improve Adult Height in Males with CAH: One of our fellows is conducting a retrospective analysis of the impact of anastrozole on predicted or final adult height in males with CAH and significantly advanced bone ages. A poster of preliminary data was presented at the Pediatric Endocrine Society meeting in May 2024.
4. Current Advances in the Management of CAH: Two of our fellows have written a review on updates in CAH. It was published in Advances in Pediatrics 2024. Vol 71(1):135-149.
5. Long-term outcomes of CAH patients (age 18+) following reduction clitoroplasty
CONTACT
2414 Morris Avenue, Ste 110
Union, NJ 07083
Phone: (908) 364-0272
Toll Free: (866) 227-3737
Fax: (908) 686-2019
contact@caresfoundation.org